Cargando…
PB1820: CD47-BLOCKER TTI-622 COMBINED WITH AZACITIDINE IN PATIENTS WITH TP53-MUTATED ACUTE MYELOID LEUKEMIA (AML) AND WITH AZACITIDINE + VENETOCLAX IN ELDERLY OR UNFIT PATIENTS WITH TP53-WILDTYPE AML
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430693/ http://dx.doi.org/10.1097/01.HS9.0000850132.55221.5c |
| _version_ | 1784779845186617344 |
|---|---|
| author | Daver, N. Maris, M. Ramchandren, R. Bixby, D. Doucette, K. Mawad, R. Egan, D. Stevens, D. Zonder, J. Molloy, N. Scheuber, A. Bruns, I. Mantzaris, I. Konopleva, M. Goldberg, A. D. |
| author_facet | Daver, N. Maris, M. Ramchandren, R. Bixby, D. Doucette, K. Mawad, R. Egan, D. Stevens, D. Zonder, J. Molloy, N. Scheuber, A. Bruns, I. Mantzaris, I. Konopleva, M. Goldberg, A. D. |
| author_sort | Daver, N. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430693 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94306932022-08-31 PB1820: CD47-BLOCKER TTI-622 COMBINED WITH AZACITIDINE IN PATIENTS WITH TP53-MUTATED ACUTE MYELOID LEUKEMIA (AML) AND WITH AZACITIDINE + VENETOCLAX IN ELDERLY OR UNFIT PATIENTS WITH TP53-WILDTYPE AML Daver, N. Maris, M. Ramchandren, R. Bixby, D. Doucette, K. Mawad, R. Egan, D. Stevens, D. Zonder, J. Molloy, N. Scheuber, A. Bruns, I. Mantzaris, I. Konopleva, M. Goldberg, A. D. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430693/ http://dx.doi.org/10.1097/01.HS9.0000850132.55221.5c Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Daver, N. Maris, M. Ramchandren, R. Bixby, D. Doucette, K. Mawad, R. Egan, D. Stevens, D. Zonder, J. Molloy, N. Scheuber, A. Bruns, I. Mantzaris, I. Konopleva, M. Goldberg, A. D. PB1820: CD47-BLOCKER TTI-622 COMBINED WITH AZACITIDINE IN PATIENTS WITH TP53-MUTATED ACUTE MYELOID LEUKEMIA (AML) AND WITH AZACITIDINE + VENETOCLAX IN ELDERLY OR UNFIT PATIENTS WITH TP53-WILDTYPE AML |
| title | PB1820: CD47-BLOCKER TTI-622 COMBINED WITH AZACITIDINE IN PATIENTS WITH TP53-MUTATED ACUTE MYELOID LEUKEMIA (AML) AND WITH AZACITIDINE + VENETOCLAX IN ELDERLY OR UNFIT PATIENTS WITH TP53-WILDTYPE AML |
| title_full | PB1820: CD47-BLOCKER TTI-622 COMBINED WITH AZACITIDINE IN PATIENTS WITH TP53-MUTATED ACUTE MYELOID LEUKEMIA (AML) AND WITH AZACITIDINE + VENETOCLAX IN ELDERLY OR UNFIT PATIENTS WITH TP53-WILDTYPE AML |
| title_fullStr | PB1820: CD47-BLOCKER TTI-622 COMBINED WITH AZACITIDINE IN PATIENTS WITH TP53-MUTATED ACUTE MYELOID LEUKEMIA (AML) AND WITH AZACITIDINE + VENETOCLAX IN ELDERLY OR UNFIT PATIENTS WITH TP53-WILDTYPE AML |
| title_full_unstemmed | PB1820: CD47-BLOCKER TTI-622 COMBINED WITH AZACITIDINE IN PATIENTS WITH TP53-MUTATED ACUTE MYELOID LEUKEMIA (AML) AND WITH AZACITIDINE + VENETOCLAX IN ELDERLY OR UNFIT PATIENTS WITH TP53-WILDTYPE AML |
| title_short | PB1820: CD47-BLOCKER TTI-622 COMBINED WITH AZACITIDINE IN PATIENTS WITH TP53-MUTATED ACUTE MYELOID LEUKEMIA (AML) AND WITH AZACITIDINE + VENETOCLAX IN ELDERLY OR UNFIT PATIENTS WITH TP53-WILDTYPE AML |
| title_sort | pb1820: cd47-blocker tti-622 combined with azacitidine in patients with tp53-mutated acute myeloid leukemia (aml) and with azacitidine + venetoclax in elderly or unfit patients with tp53-wildtype aml |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430693/ http://dx.doi.org/10.1097/01.HS9.0000850132.55221.5c |
| work_keys_str_mv | AT davern pb1820cd47blockertti622combinedwithazacitidineinpatientswithtp53mutatedacutemyeloidleukemiaamlandwithazacitidinevenetoclaxinelderlyorunfitpatientswithtp53wildtypeaml AT marism pb1820cd47blockertti622combinedwithazacitidineinpatientswithtp53mutatedacutemyeloidleukemiaamlandwithazacitidinevenetoclaxinelderlyorunfitpatientswithtp53wildtypeaml AT ramchandrenr pb1820cd47blockertti622combinedwithazacitidineinpatientswithtp53mutatedacutemyeloidleukemiaamlandwithazacitidinevenetoclaxinelderlyorunfitpatientswithtp53wildtypeaml AT bixbyd pb1820cd47blockertti622combinedwithazacitidineinpatientswithtp53mutatedacutemyeloidleukemiaamlandwithazacitidinevenetoclaxinelderlyorunfitpatientswithtp53wildtypeaml AT doucettek pb1820cd47blockertti622combinedwithazacitidineinpatientswithtp53mutatedacutemyeloidleukemiaamlandwithazacitidinevenetoclaxinelderlyorunfitpatientswithtp53wildtypeaml AT mawadr pb1820cd47blockertti622combinedwithazacitidineinpatientswithtp53mutatedacutemyeloidleukemiaamlandwithazacitidinevenetoclaxinelderlyorunfitpatientswithtp53wildtypeaml AT egand pb1820cd47blockertti622combinedwithazacitidineinpatientswithtp53mutatedacutemyeloidleukemiaamlandwithazacitidinevenetoclaxinelderlyorunfitpatientswithtp53wildtypeaml AT stevensd pb1820cd47blockertti622combinedwithazacitidineinpatientswithtp53mutatedacutemyeloidleukemiaamlandwithazacitidinevenetoclaxinelderlyorunfitpatientswithtp53wildtypeaml AT zonderj pb1820cd47blockertti622combinedwithazacitidineinpatientswithtp53mutatedacutemyeloidleukemiaamlandwithazacitidinevenetoclaxinelderlyorunfitpatientswithtp53wildtypeaml AT molloyn pb1820cd47blockertti622combinedwithazacitidineinpatientswithtp53mutatedacutemyeloidleukemiaamlandwithazacitidinevenetoclaxinelderlyorunfitpatientswithtp53wildtypeaml AT scheubera pb1820cd47blockertti622combinedwithazacitidineinpatientswithtp53mutatedacutemyeloidleukemiaamlandwithazacitidinevenetoclaxinelderlyorunfitpatientswithtp53wildtypeaml AT brunsi pb1820cd47blockertti622combinedwithazacitidineinpatientswithtp53mutatedacutemyeloidleukemiaamlandwithazacitidinevenetoclaxinelderlyorunfitpatientswithtp53wildtypeaml AT mantzarisi pb1820cd47blockertti622combinedwithazacitidineinpatientswithtp53mutatedacutemyeloidleukemiaamlandwithazacitidinevenetoclaxinelderlyorunfitpatientswithtp53wildtypeaml AT konoplevam pb1820cd47blockertti622combinedwithazacitidineinpatientswithtp53mutatedacutemyeloidleukemiaamlandwithazacitidinevenetoclaxinelderlyorunfitpatientswithtp53wildtypeaml AT goldbergad pb1820cd47blockertti622combinedwithazacitidineinpatientswithtp53mutatedacutemyeloidleukemiaamlandwithazacitidinevenetoclaxinelderlyorunfitpatientswithtp53wildtypeaml |